Tics Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Tics clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 129 trials

Recruiting

Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques

TicsFunctional Tics
National Institute of Neurological Disorders and Stroke (NINDS)75 enrolled1 locationNCT07137442
Recruiting
Not Applicable

Effects of Antipsychotics on Brain Insulin Action in Females

Insulin ResistanceMenstrual CycleType 2 Diabetes+1 more
Centre for Addiction and Mental Health15 enrolled1 locationNCT06251635
Recruiting

Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)

Rate of CKD Diagnosis in Patients With AH and CKD MarkersDemographic and Clinical Characteristics for Those PatientsRoutine Therapy Before and After the Diagnosis of CKD
AstraZeneca1,282 enrolled19 locationsNCT06744335
Recruiting
Phase 4

The STOP-MED CTRCD Trial

Heart FailureCancerCardiotoxicity+2 more
Dinesh Thavendiranathan335 enrolled14 locationsNCT06183437
Recruiting

The Combined First Trimester Screening

Fetal Growth RestrictionPreterm LaborPreeclampsia (PE)+4 more
Institute of Health Information and Statistics of the Czech Republic2,000 enrolled3 locationsNCT07015203
Recruiting
Not Applicable

Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure

Heart FailureDiuretics
Cardiology Research UBC300 enrolled1 locationNCT07369856
Recruiting
Phase 1

Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Pharmacokinetics After Oral Intake
Iterum Therapeutics, International Limited12 enrolled1 locationNCT07092813
Recruiting

Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia

Altered State of ConsciousnessGeneral Anesthetics
Huazhong University of Science and Technology250 enrolled1 locationNCT07410702
Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+17 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting

Helix Research Network

Genetic Predisposition to DiseaseGenetics Disease
Helix, Inc2,000,000 enrolled14 locationsNCT06057181
Recruiting
Phase 2

CBIT+TMS R33 Phase

Tourette SyndromeTics
University of Minnesota60 enrolled1 locationNCT06678737
Recruiting
Phase 4

Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children

Pharmacokinetics of Tafenoquine
Curtin University30 enrolled1 locationNCT07052162
Recruiting
Phase 1

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Healthy ParticipantsPharmacokinetics
Amgen400 enrolled4 locationsNCT07422285
Recruiting

Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy

Turner SyndromeGalactosemiaPost-menarcheal Adolescents+3 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)200 enrolled1 locationNCT04948658
Recruiting
Not Applicable

Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis

InfertilityEndometriosisEpigenetics+7 more
Centre Hospitalier Universitaire, Amiens160 enrolled1 locationNCT07471373
Recruiting

Ultrasound Image Bank: Advancing Medical Research and Diagnostics

Gynecologic DiseaseGynecological ImagingUltrasound Diagnostics
Fondazione Policlinico Universitario Agostino Gemelli IRCCS25,000 enrolled1 locationNCT07031921
Recruiting
Not Applicable

Genomic of CONgenital Sideroblastic Anemias

AnemiaGeneticsErythropoiesis
Centre Hospitalier Universitaire, Amiens20 enrolled1 locationNCT07459816
Recruiting
Not Applicable

Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

TuberculosisDiagnosticsGlobal Health
University of California, San Francisco2,100 enrolled3 locationsNCT05989802
Recruiting
Phase 1

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

Pharmacokinetics
Ensysce Biosciences30 enrolled1 locationNCT06500793
Recruiting
Not Applicable

Haptics in Virtual Reality

LiteracyLiteracy-language InterventionHaptics
University of Miami60 enrolled2 locationsNCT07209228